In 1987, Mayeux et al. reported the first case of myoclonus secondary to an acetylcholinesterase inhibitor.9 They described two patients with Alzheimer’s disease for whom physostigmine was prescribed. The gene discussed is ACHE; the disease is Alzheimer disease.